Antioxidant Treatment of Type 2 Diabetes

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.

Key facts

Study ID

NCT00609102

Run by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

People needed

44

Starts

2008-07-01

Expected to finish

2013-09-01

Last updated by the study team

2014-12-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• Pacific Northwest Research Institute — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.